Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.4 EUR | +1.58% | +5.36% | +14.29% |
Mar. 22 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
Mar. 15 | REDCARE PHARMACY : Buy rating from Hauck & Aufhauser | ZD |
Sales 2024 * | 2.38B 2.57B | Sales 2025 * | 2.91B 3.14B | Capitalization | 3.01B 3.25B |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.48M | Net income 2025 * | 49M 52.93M | EV / Sales 2024 * | 1.34 x |
Net Debt 2024 * | 172M 186M | Net Debt 2025 * | 156M 168M | EV / Sales 2025 * | 1.09 x |
P/E ratio 2024 * |
-451
x | P/E ratio 2025 * |
72.5
x | Employees | 1,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.9% |
Latest transcript on Redcare Pharmacy NV
1 day | -0.92% | ||
1 week | +5.49% | ||
Current month | +6.54% | ||
1 month | +4.63% | ||
3 months | +10.90% | ||
6 months | +53.74% | ||
Current year | +13.22% |
Managers | Title | Age | Since |
---|---|---|---|
Stephan Weber
FOU | Founder | - | 00-12-31 |
Marc Fischer
FOU | Founder | - | 00-12-31 |
Olaf Heinrich
CEO | Chief Executive Officer | 54 | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn H. Söder
CHM | Chairman | 52 | 15-12-31 |
Frank Köhler
FOU | Founder | 60 | 00-12-31 |
Director/Board Member | 53 | 22-04-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 17 M€ | -.--% | - | |
0.02% | 735 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 150.6 | +1.04% | 51 984 |
24-03-27 | 149 | +5.64% | 130,863 |
24-03-26 | 141 | -4.53% | 98,125 |
24-03-25 | 147.8 | +1.76% | 71,430 |
24-03-22 | 145.2 | +1.72% | 61,367 |
Delayed Quote Xetra, March 27, 2024 at 12:36 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.22% | 3.26B | |
-19.49% | 18.13B | |
-29.16% | 11.09B | |
-2.90% | 6.79B | |
-0.60% | 5.57B | |
+10.80% | 5.26B | |
+34.14% | 3.93B | |
-9.43% | 3.75B | |
+4.30% | 3.55B | |
-15.38% | 3.32B |